6月18日 - ** 生物技术公司 Regencell Bioscience RGC.O 的股价在盘前交易中下跌 12.2
** 股票拆分启动后，股价在过去两个交易日上涨了五倍
** 该公司于6月2日宣布了38对1的正向股票拆分
** RGC 开发治疗神经认知障碍的传统中药
** 2025 年初 RGC 的股价为 13 美分
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.